MoonLake Immunotherapeutics (MLTX), a clinical-stage biotechnology company, is scheduled to report 24-week data from its ARGO trial on March 10, 2024.
ARGO is a global phase II trial of the company's lead drug candidate Sonelokimab in active psoriatic arthritis.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.